cdmo.directory
← Compare landing

Adragos Pharma vs Catalent

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/adragos-pharma/catalent

CategoryAdragos PharmaCatalent
Listed sitecdmocdmo
SummaryGlobal CDMO headquartered in Munich offering end-to-end development and manufacturing for small molecules and biologics, including sterile/non-sterile liquids, solids, semi-solids, lyophilization, and prefilled syringes across seven facilities in Europe and Japan.Global CDMO providing end-to-end contract development and manufacturing for pharma, biotech, and consumer health. Delivers 60+ billion doses annually across small molecules, biologics, cell & gene therapies, and clinical supply.
Services
  • Formulation Development
  • CMC Analytical Development
  • Process Development
  • Stability Testing & Storage
  • Quality Control Testing
  • CMC Regulatory Submission Support
  • HPAPI Manufacturing (High-Potency)
  • Lyophilization (Freeze Drying)
  • Prefilled Syringe (PFS) Filling
  • Vial Filling
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Oral Solid Dosage Manufacturing
  • Topical & Semi-Solid Manufacturing
  • Cold-Chain Storage & Logistics
  • Secondary Packaging & Labeling
  • Technology Transfer
  • Monoclonal Antibody (mAb) Manufacturing
  • Cell Therapy Manufacturing
  • Viral Vector Manufacturing
  • AAV Manufacturing
  • Oral Solid Dosage Manufacturing
  • Inhalation & Nasal Dosage Manufacturing
  • Formulation Development
  • Process Development
  • CMC Analytical Development
  • Technology Transfer
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Quality Control Testing
  • Recombinant Protein Manufacturing
  • Biologics Development & Manufacturing
  • API Synthesis & Manufacturing
  • Small Molecule Development & Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Secondary Packaging & Labeling
  • Stability Testing & Storage
  • CMC Regulatory Submission Support
  • Allogeneic Cell Therapy Manufacturing
  • Autologous Cell Therapy Manufacturing
  • Cell-Line Development
  • Upstream Processing
  • Downstream Processing
  • Vial Filling
  • Prefilled Syringe (PFS) Filling
  • Topical & Semi-Solid Manufacturing
  • Serialization & Track-and-Trace
  • Cold-Chain Storage & Logistics
  • Cartridge Filling
  • Lyophilization (Freeze Drying)
  • Lentiviral Vector Manufacturing
Modalities
  • Biologics (Monoclonal Antibodies)
  • Small Molecule
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
  • AAV / Viral Vector Platform
Indications
  • Women's Health
Data not yet provided.
Locations
  • Headquarters, Munich, Bavaria, Germany
  • Development & Manufacturing, Athens, Attica, Greece
  • Manufacturing, Halden, Østfold, Norway
  • Manufacturing, Jura, Bourgogne-Franche-Comté, France
  • Manufacturing, Kawagoe, Saitama, Japan
  • Manufacturing, Livron, Auvergne-Rhône-Alpes, France
  • Manufacturing, Leipzig, Saxony, Germany
  • Manufacturing, Maisons-Alfort, Île-de-France, France
  • Headquarters, United States
  • Asia Pacific, Asia Pacific
  • Europe, Europe
  • Latin America, Latin America
  • North America, North America, United States
  • China, China
  • Japan, Japan
  • North America, North America
  • Headquarters / Global Operations
  • Cell Therapy Center of Excellence, Princeton, New Jersey, United States
  • Soft Chew Manufacturing, Manassas, Virginia, United States
  • Global Network
CertificationsData not yet provided.
  • GMP · Identifier: Nine GMP facilities
  • FDA · Identifier: 21 CFR 111
  • FDA · Identifier: 21 CFR 117
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.